Sartorius Stedim Biotech S.A. (DIM.PA)
EUR 211.5
(2.57%)
EUR 211.5
(2.57%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 882.4 Million EUR | -13.9% |
| 2022 | 1.02 Billion EUR | 30.89% |
| 2021 | 782.95 Million EUR | 65.77% |
| 2020 | 472.3 Million EUR | 43.92% |
| 2019 | 328.16 Million EUR | 30.22% |
| 2018 | 252 Million EUR | 35.77% |
| 2017 | 185.6 Million EUR | 8.5% |
| 2016 | 171.05 Million EUR | 16.39% |
| 2015 | 146.97 Million EUR | 33.64% |
| 2014 | 109.97 Million EUR | 19.31% |
| 2013 | 92.17 Million EUR | 8.34% |
| 2012 | 85.07 Million EUR | 28.07% |
| 2011 | 66.43 Million EUR | 30.83% |
| 2010 | 50.77 Million EUR | 8.69% |
| 2009 | 46.71 Million EUR | -23.31% |
| 2008 | 60.91 Million EUR | 13.33% |
| 2007 | 53.75 Million EUR | -24.01% |
| 2006 | 70.73 Million EUR | 1.59% |
| 2005 | 69.62 Million EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 745.7 Million EUR | -6.45% |
| 2024 Q2 | 797.1 Million EUR | -8.66% |
| 2024 Q1 | 872.7 Million EUR | -1.1% |
| 2023 Q3 | 992 Million EUR | -3.98% |
| 2023 Q1 | 1.06 Billion EUR | 3.52% |
| 2023 Q2 | 1.03 Billion EUR | -2.62% |
| 2023 Q4 | 882.4 Million EUR | -11.05% |
| 2023 FY | 882.4 Million EUR | -13.9% |
| 2022 Q1 | 857.5 Million EUR | 9.52% |
| 2022 Q4 | 1.02 Billion EUR | -3.19% |
| 2022 Q3 | 1.05 Billion EUR | 9.8% |
| 2022 Q2 | 964.1 Million EUR | 12.43% |
| 2022 FY | 1.02 Billion EUR | 30.89% |
| 2021 Q3 | 703.9 Million EUR | 17.39% |
| 2021 Q4 | 782.95 Million EUR | 11.23% |
| 2021 Q1 | 534.8 Million EUR | 13.23% |
| 2021 Q2 | 599.6 Million EUR | 12.12% |
| 2021 FY | 782.95 Million EUR | 65.77% |
| 2020 FY | 472.3 Million EUR | 43.92% |
| 2020 Q2 | 407.9 Million EUR | 19.79% |
| 2020 Q3 | 437.5 Million EUR | 7.26% |
| 2020 Q4 | 472.3 Million EUR | 7.96% |
| 2020 Q1 | 340.5 Million EUR | 3.76% |
| 2019 Q3 | 314.4 Million EUR | 9.97% |
| 2019 FY | 328.16 Million EUR | 30.22% |
| 2019 Q2 | 285.9 Million EUR | 5.93% |
| 2019 Q1 | 269.9 Million EUR | 7.1% |
| 2019 Q4 | 328.16 Million EUR | 4.38% |
| 2018 Q1 | 203 Million EUR | 9.37% |
| 2018 FY | 252 Million EUR | 35.77% |
| 2018 Q4 | 252 Million EUR | 5.0% |
| 2018 Q3 | 240 Million EUR | 11.27% |
| 2018 Q2 | 215.7 Million EUR | 6.26% |
| 2017 Q2 | 179.8 Million EUR | -0.55% |
| 2017 FY | 185.6 Million EUR | 8.5% |
| 2017 Q1 | 180.8 Million EUR | 5.7% |
| 2017 Q4 | 185.6 Million EUR | 0.87% |
| 2017 Q3 | 184 Million EUR | 2.34% |
| 2016 FY | 171.05 Million EUR | 16.39% |
| 2016 Q1 | 160.5 Million EUR | 9.21% |
| 2016 Q2 | 170.3 Million EUR | 6.11% |
| 2016 Q3 | 175 Million EUR | 2.76% |
| 2016 Q4 | 171.05 Million EUR | -2.25% |
| 2015 Q4 | 146.97 Million EUR | 6.27% |
| 2015 Q3 | 138.3 Million EUR | 0.44% |
| 2015 Q2 | 137.7 Million EUR | 8.43% |
| 2015 Q1 | 127 Million EUR | 15.48% |
| 2015 FY | 146.97 Million EUR | 33.64% |
| 2014 FY | 109.97 Million EUR | 19.31% |
| 2014 Q4 | 109.97 Million EUR | -6.24% |
| 2014 Q3 | 117.3 Million EUR | 10.76% |
| 2014 Q2 | 105.9 Million EUR | 6.54% |
| 2014 Q1 | 99.4 Million EUR | 4.7% |
| 2013 Q3 | 94.7 Million EUR | 5.57% |
| 2013 Q4 | 94.93 Million EUR | 0.25% |
| 2013 Q2 | 89.7 Million EUR | -3.34% |
| 2013 Q1 | 92.8 Million EUR | 9.08% |
| 2013 FY | 92.17 Million EUR | 8.34% |
| 2012 Q2 | 78 Million EUR | 0.0% |
| 2012 FY | 85.07 Million EUR | 28.07% |
| 2012 Q4 | 85.07 Million EUR | 0.0% |
| 2011 Q2 | 62.5 Million EUR | 0.0% |
| 2011 FY | 66.43 Million EUR | 30.83% |
| 2010 Q2 | 56.6 Million EUR | 0.0% |
| 2010 FY | 50.77 Million EUR | 8.69% |
| 2009 FY | 46.71 Million EUR | -23.31% |
| 2009 Q4 | 46.71 Million EUR | 0.0% |
| 2008 FY | 60.91 Million EUR | 13.33% |
| 2007 FY | 53.75 Million EUR | -24.01% |
| 2006 FY | 70.73 Million EUR | 1.59% |
| 2005 FY | 69.62 Million EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Crossject Société Anonyme | 3.13 Million EUR | -28055.712% |
| Safe Orthopaedics SA | 4.5 Million EUR | -19469.749% |
| Spineway SA | 4.4 Million EUR | -19945.434% |
| Amplitude Surgical SA | 43.3 Million EUR | -1937.875% |
| EssilorLuxottica Société anonyme | 2.75 Billion EUR | 67.913% |
| bonyf N.V. | 37.33 Thousand EUR | -2363619.161% |